What's Happening?
Aricca Wallace, a Kansas mother of two, was diagnosed with Stage 3 cervical cancer after her annual pap smears failed to detect a tumor the size of a baby's head. Despite undergoing extensive chemotherapy and radiation, her cancer spread, and she was given
less than a year to live in 2012. However, Wallace participated in a clinical trial in Maryland, which involved a new treatment developed by the National Cancer Institute and Rutgers Cancer Institute. This trial, which used immune cells to fight the cancer, ultimately led to her being cancer-free for over 13 years. Wallace now raises awareness about cervical cancer alongside Dr. Christian Hinrichs, who treated her during the trial.
Why It's Important?
Wallace's story highlights the potential of clinical trials in providing new hope for cancer patients, especially those with limited treatment options. Her survival underscores the importance of continued research and development in cancer treatments, which can lead to breakthroughs that save lives. The trial she participated in represents a significant advancement in the fight against cervical cancer, a disease with a challenging prognosis. Wallace's advocacy work also emphasizes the need for awareness and early detection, which can improve outcomes for others facing similar diagnoses.
What's Next?
The clinical trial that saved Wallace's life continues to undergo research, with a focus on using genetically engineered cells to fight cancer. This approach could potentially become a standard therapy in the future, offering new hope to patients with advanced cervical cancer. As Wallace continues her advocacy, she aims to inspire others to participate in clinical trials and advocate for themselves in their healthcare journeys.
